Novo Nordisk reports 2025 sales growth, cuts 2026 outlook
Go back to Novo Nordisk reports 2025 sales growth, cuts 2026 outlook| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.60 -0.91 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.51 | 52 Week High | $59.00 | |||
| Open | $46.35 | 52 Week Low | $32.80 | |||
| Day High | $46.74 | P/E | N/A | |||
| Day Low | $46.04 | EPS | $0.00 | |||
| Volume | 6,219,249 | |||||

